Company Name Madison Vaccines
Mailing Address 505 South Rosa Road Madison, WI 53719
Company Description The principal mission of Madison, Wisconsin-based MVI is the development of therapeutic plasmid DNA vaccine products for patients with prostate cancer. MVI is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines.
Proceeds Purposes The proceeds will support ongoing development of MVI’s pipeline, including completion of an expanded Phase 2 clinical trial for MVI-816 in non-metastatic prostate cancer patients with rapidly rising PSA, before the need for surgical or chemical castration (androgen deprivation therapy or ADT).
Venture Investor Venture Investors
Venture Investor WARF
Venture Investor Venture Management
Venture Investor State of Wisconsin Investment Board